Sandy Draper
Stock Analyst at Guggenheim
(3.55)
# 908
Out of 4,761 analysts
125
Total ratings
56%
Success rate
18.03%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $340.22 | +26.98% | 12 | Jul 24, 2024 | |
| ACCD Accolade | Maintains: Buy | $13 → $6 | $6.93 | -13.42% | 5 | Jun 28, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $191.04 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $163.02 | - | 15 | Feb 15, 2024 | |
| EVH Evolent Health | Maintains: Hold | $36 → $34 | $10.43 | +225.98% | 9 | Nov 14, 2023 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $4.81 | +107.90% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $72.37 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $0.89 | +124.74% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $201.39 | +30.59% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $3.52 | +752.27% | 3 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $94 | $108.60 | -13.44% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $11.51 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $24.52 | +107.99% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $162.31 | -20.52% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $39.18 | +40.38% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $49.26 | +241.05% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $49.28 | -75.65% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $0.22 | +81,718.18% | 1 | Mar 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $33 → $38 | $18.61 | +104.19% | 7 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $4.72 | +960.45% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $11.10 | +485.59% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $5.23 | +588.34% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $225.79 | -26.04% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.64 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $16.51 | +281.59% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $340.22
Upside: +26.98%
Accolade
Jun 28, 2024
Maintains: Buy
Price Target: $13 → $6
Current: $6.93
Upside: -13.42%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $191.04
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $163.02
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36 → $34
Current: $10.43
Upside: +225.98%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $4.81
Upside: +107.90%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $72.37
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $0.89
Upside: +124.74%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $201.39
Upside: +30.59%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $3.52
Upside: +752.27%
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $108.60
Upside: -13.44%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $11.51
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $24.52
Upside: +107.99%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $162.31
Upside: -20.52%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $39.18
Upside: +40.38%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $49.26
Upside: +241.05%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $49.28
Upside: -75.65%
Mar 29, 2021
Initiates: Buy
Price Target: $180
Current: $0.22
Upside: +81,718.18%
Feb 4, 2021
Maintains: Hold
Price Target: $33 → $38
Current: $18.61
Upside: +104.19%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $4.72
Upside: +960.45%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $11.10
Upside: +485.59%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $5.23
Upside: +588.34%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $225.79
Upside: -26.04%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.64
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $16.51
Upside: +281.59%